Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Izzet Doğan"'
Publikováno v:
European Journal of Breast Health, Vol 19, Iss 2, Pp 128-133 (2023)
Objective:The aim was to assess the prognostic variables in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer patients receiving lapatinib plus capecitabine.Materials and Methods:Retrospective data on HER2-positive met
Externí odkaz:
https://doaj.org/article/82be6058db504093bd5493194317ce8d
Publikováno v:
European Journal of Breast Health, Vol 18, Iss 4, Pp 323-328 (2022)
Objective:Published studies on male breast cancer (MBC) and BRCA mutations are scarce and usually include, a small number of patients. The clinicopathological characteristics of BRCA mutant and wild-type MBC patients were compared in more than forty
Externí odkaz:
https://doaj.org/article/493a4dc1f5d040a9b2c9db63d93ad580
Autor:
İzzet Doğan, Didem Taştekin
Publikováno v:
Bagcilar Medical Bulletin, Vol 7, Iss 2, Pp 144-149 (2022)
Objective:Small bowel adenocarcinoma is a rare tumor, and data on prognosis are limited. We aimed to evaluate the clinicopathological features and prognostic factors in small bowel adenocarcinoma in this study.Method:Twenty-two patients were evaluate
Externí odkaz:
https://doaj.org/article/4676a1b23bcb45529ab64a49dc745afc
Publikováno v:
Cam & Sakura Medical Journal, Vol 2, Iss 1, Pp 8-13 (2022)
Objective: To assess the effect of adjuvant chemotherapy on insulin resistance in patients with early breast cancer. Material and Methods: Twenty-three non-diabetic patients were included. Patients were prospectively evaluated before, during, and aft
Externí odkaz:
https://doaj.org/article/11863c170450433285b19bfee728ede7
Autor:
Mustafa Gürbüz, İzzet Doğan, Erman Akkuş, Hilal Özakıncı, Pınar Kubilay Tolunay, Ender Kalacı, Tolga Bağlan, Elif Berna Köksoy, Koray Ceyhan, Serpil Dizbay Sak, Adnan Aydınder, Ahmet Demirkazık, Güngör Utkan
Publikováno v:
Tuberk Toraks. 70:132-140
Clinicopathological parameters related to programmed death ligand 1 (PD-L1) expression levels have been investigated in several studies. However, the results of these studies are conflicting and vary in different populations. This study aimed to inve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d71c51bb045e60c55d5e555559bb170f
https://doi.org/10.5578/tt.20229803
https://doi.org/10.5578/tt.20229803
Autor:
Seval Ay, Muhammed Mustafa Atcı, Rukiye Arıkan, Özgecan Dülgar, Deniz Tataroğlu Özyükseler, Nail Paksoy, İzzet Doğan, Buğra Öztosun, Didem Taştekin, Başak Bala Öven, Mahmut Gümüş
Publikováno v:
Journal of Chemotherapy. 34:465-471
Pancreas cancer (PCa) is one of the mortal cancer types with ranking as fourth leading cancer death in both sexes together. FOLFIRINOX (FFX) and Gemcitabine plus nab-paclitaxel (GNP) are approved as first-line metastatic treatment in PCa. The aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12f24abf478c56e94abd1b17617a1826
https://doi.org/10.1080/1120009x.2022.2026125
https://doi.org/10.1080/1120009x.2022.2026125
Autor:
Mustafa GÜRBÜZ, İzzet DOĞAN, Erman AKKUŞ, İbrahim KARADAĞ, Serdar KARAKAYA, Cihan EROL, Ramazan ACAR, Mert KARAOĞLAN, Elif Berna KÖKSOY, Berna SAVAŞ, Mehmet Ali Nahit ŞENDUR, Didem TAŞTEKİN, Nuri KARADURMUŞ, Ömür Berna ÇAKMAK ÖKSÜZOĞLU, Filiz ÇAY ŞENLER
Publikováno v:
Journal of Oncological Sciences. 8:14-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3cdb0da2552ee4ac1fd82ea49f47949
https://doi.org/10.37047/jos.2021-86554
https://doi.org/10.37047/jos.2021-86554
Autor:
Yeşim ERALP, İzzet DOĞAN, Sercan Aksoy, Burcu ÇAKAR, Gül BAŞARAN, Özlem ERCELEP, Nil MOLİNAS MANDEL, Taner KORKMAZ, Erhan GÖKMEN, Adnan AYDINER, Pınar SAİP
Publikováno v:
Cancer Research. 83:P3-02
Background: Although HER2 is an aggressive subtype of BC, the outcomes have improved over the past two decades due to advances in targeted therapies. Here, we present data of HER2-positive subset from the multicenter registry study of the Turkish Onc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f42d288597a877ba9328aed287ae43a1
https://doi.org/10.1158/1538-7445.sabcs22-p3-02-06
https://doi.org/10.1158/1538-7445.sabcs22-p3-02-06
Autor:
Nail Paksoy, Nijat Khanmammadov, İzzet Doğan, Ferhat Ferhatoğlu, Melin Aydan Ahmed, Sule Karaman, Adnan Aydiner
Publikováno v:
Medicine. 102:e32866
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62e0623360319e377d3e4336b623a6a0
https://doi.org/10.1097/md.0000000000032866
https://doi.org/10.1097/md.0000000000032866
Autor:
Emre Yekedüz, İzzet Doğan, Dılşa Mızrak Kaya, İlker Özgür, Güngör Utkan, Sezai Vatansever, Salim Demirci, Hakan Akbulut, Yüksel Ürün
Aim To evaluate the prognostic role of the systemic immune-inflammation index (SII) in patients with operable gastric cancer. Methods We assessed 354 patients with operable gastric cancer from tertiary centers in Turkey. SII was calculated by followi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e990624ada482b0bf9e81736b832641
https://doi.org/10.21203/rs.3.rs-1042125/v1
https://doi.org/10.21203/rs.3.rs-1042125/v1
